Kolon TissueGene, Inc. is a US-based clinical-stage biopharmaceutical company dedicated to developing advanced cell therapies, notably including its product candidate TG-C.…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Kolon TissueGene, Inc. →Already a subscriber? Sign in
Xcout Intel tracks Kolon TissueGene, Inc. continuously — this profile deepens as new filings, funding, people and hiring data arrive.
Work at Kolon TissueGene, Inc.? Claim this profile